| COVID-19 |
1 |
1 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.87 |
| Heart |
0 |
0.99 |
| Biologic Therapy |
0 |
0.3 |
| Cancer |
0 |
0.27 |
| Cardiac Tumor |
0 |
0.23 |
| Revenue and Practice Management |
0 |
0.14 |
| Clinical Research |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Pandemic |
0 |
0.11 |
| Health Insurance |
0 |
0.08 |
| Workers' Compensation System |
0 |
0.08 |
| Multiple Sclerosis |
0 |
0.06 |
| Neuroendocrine Tumor |
0 |
0.06 |